1Dentali F, Sironi AP, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature [J]. Semin Thromb Hemost, 2012, 38: 535-548.
2Tregou DA, Heath S, Saut N, et ah Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach [J] . Blood, 2009, 113: 5298-5303.
3Teupser D, Baber R, Ceglarek U, et ah Genetic regulation of serum phytosterol levels and risk of coronary artery disease [J].Circ Cardiovase Genet, 2010, 3: 331-339.
4Shan Zhou and Ian Welsby. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? [J]. World J Cardiol, 2014 6 (9): 985-992.
5Rios DR, Fernandes AP, Figueiredo RC, et al. Relationship between ABO blood groups and yon Willebrand factor, ADAMTSI 3 and factor VIII in patients undergoing hemodialysi [J] s. J Thromb Thrombolysis, 2012, 33 (4):416-421.
6Wautrecht JC, Galle C, Motte S, et ah The role of ABO blood groups in the incidence of deep vein thrombosis [J] . Thromb Haem ost, 1998, 79:688-689.
7Bittar LF, de Paula EV, Mello TB, et ah Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plas- ma levels of FVIII and vWF in patients with deep venous thrombosis [J] . Clin Appl Thromb Hemost, 2011 , 17 (5) : 514-518.
8Jenkins PV, O' Donnell JS. ABO blood group determines plasma yon Willebrand factor levels: a biologic function after all? [J].Transfusion, 2006, 46 (10): 1836-1844.
9Wiggins KL, Smith NL, Glazer NL, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke [J] . Journal of Thrombosis and Haemostasis, 2009, 7 (2): 263-269.
10Klarmann D, Eggert C, Geisen C, et al. Association of ABO (H) and I blood group system development with yon Willebrand factor and Factor VIII plasma levels in children and adolescents [J] . Transfusion, 2010, 50 (7): 1571-1580.